SCHEMBL24309876

SCHEMBL24309876

CN(Sc1ccccc1)c1nc(Oc2ccccc2)cc(-c2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MEN1 O00255 6/20 0.43
▸ KMT2A Q03164 6/20 0.43
▸ MAPT P10636 4/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ATM Q13315 2/20 0.43
▸ GLA P06280 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ LOXL2 Q9Y4K0 1/20 0.39
▸ ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309874 0.74 MAPK1 (0.52) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL11978702 0.72 MAPK1 (0.70) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL14987893 0.72 MAPK1 (1.00) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL24309752 0.70 MAPK1 (0.57) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL24309569 0.69 TDP1 (0.70) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL24309604 0.69 MAPK1 (0.70) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL24310546 0.67 MAPK1 (0.49) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL4268518 0.65 LTA4H (0.60) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL14987882 0.65 MAPK1 (0.82) MAPK1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL11398105 0.64 NUDT1 (0.48) MAPK1TDP1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback